Third-party Wharton’s jelly mesenchymal stem cells for treatment of steroid-resistant acute and chronic graft-versus-host disease: a report of 10 cases

Dariusz BORUCZKOWSKI, Dominika GŁADYSZ, Slawomir RUMIŃSKI, Iwona CZAPLICKA-SZMAUS, Magdalena MURZYN, Artur OLKOWICZ, Krzysztof KAŁWAK, Monika MIELCAREK, Katarzyna DRABKO, Jan STYCZYŃSKI, Miroslaw MARKIEWICZ, Katarzyna PAWELEC*, Maciej BORUCZKOWSKI, Tomasz OŁDAK Polish Stem Cell Bank, Warsaw, Poland Warsaw Medical University, Poland Department of Bone Marrow Transplantation, Pediatric Hematology and Oncology, Wroclaw Medical University, Wroclaw, Poland Department of Pediatric Hematology and Oncology and Transplantology, Medical University of Lublin, Lublin, Poland Department of Pediatric Hematology and Oncology, Collegium Medicum, UMK, Bydgoszcz, Poland Medical University of Silesia, School of Medicine in Katowice, Department of Hematology and Bone Marrow Transplantation, Katowice, Poland Department of Pediatric Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland Poznan University of Medical Sciences, Poznan, Poland